Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics

Bausch + Lomb

Status and phase: Completed; Phase 4

Conditions: Pain

Treatments: Drug: Vitrase (ovine hyaluronidase) Lyophilized

Study type: Interventional

Funder types: Industry

Identifiers

NCT00198549

ISTA-VIT-SA-MA02

Details and patient eligibility

About

The purpose of this study is to evaluate Vitrase as an adjuvant to increase absorption and dispersion of other injected anesthetics

Enrollment: 40 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Scheduled for an ophthalmic surgical procedure

Exclusion criteria

• Known allergy to bee venom

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)